← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2016Last known activity
Nov 30, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 6 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT07157735CollaboratorPhase 2Nov 30, 2025
- NCT07207057CollaboratorPhase 3Sep 12, 2025
- NCT06339034CollaboratorPhase 1/Phase 2Jul 3, 2024
- NCT03439943CollaboratorPhase 2Jun 13, 2018
- NCT02953665CollaboratorPhase 2Apr 3, 2017
- NCT02941822CollaboratorPhase 2Dec 1, 2016
Details
- Last known activity
- Nov 30, 2025